D-1487-2019 Class II Terminated
FDA drug recall D-1487-2019 was initiated by Pfizer Inc. on Jul 9, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Bags have the potential to leak. The recall status is terminated (terminated Oct 27, 2021). Affected quantity: 280340 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 24, 2019
- Initiation Date
- Jul 9, 2019
- Termination Date
- Oct 27, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 280340 bags
Product description
Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection, 20 mg/100 mL, 100 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-23, Barcode (01)00304092776233.
Reason for recall
Lack of Assurance of Sterility: Bags have the potential to leak.
Distribution pattern
United States, PR, and Guam
Code information
Lot #s: 85-516-KL; 85-517-KL, Exp. 1JAN2020; 86-601-KL; 86-603-KL; 86-618-KL, Exp. 1FEB2020; 87-707-KL, Exp. 1MAR2020; 91-205-KL, Exp. 1JUL2020; 92-306-KL, Exp. 1AUG2020.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1487-2019
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.